These results are aligned with previous findings of increased PGC1-α promoter methylation in skeletal muscle biopsies and pancreatic islets of patients with T2DM compared to normoglycemia, which were associated with decreased PGC1-α expression and insulin secretion (104, 105). Here, PPARGC1A is linked to type 2 diabetes mellitus.